Document ID: chunk:federal_register_of_legislation:C2022C00026:clause:1_16
Version: federal_register_of_legislation:C2022C00026
Segment Type: clause
Provision Reference: sch 1 cl 16
Character Range: 12511–13486

16  Subsection 99ACC(4B)
Repeal the subsection, substitute:
 (4B) If subsection (4) does not apply, then, in agreeing the new price of the single brand of the combination item, the Minister must take into account:
 (a) in relation to the listed component drug, or each listed component drug, that became subject to statutory price reduction:
 (i) the approved ex‑manufacturer price, on the reduction day, of each brand of a pharmaceutical item that has the drug that is the listed component drug; and
 (ii) the quantity of the listed component drug contained in the combination item; and
 (b) to the extent that the single brand of the combination item contains one or more component drugs that are not listed component drugs—the matters mentioned in paragraph (a) in relation to each component drug that is not a listed component drug as if a declaration under subsection 85(2) was in force in relation to each non‑listed component drug, as described in paragraph (4A)(e).